论文部分内容阅读
徐明波.双鹭药业股份有限公司总经理,董事长,为公司主要发起人、创办者和核心技术带头人。历任军事医学科学院课题组长、助理研究员、北京双鹭药业股份有限公司高级工程师、教授级高级工程师、总经理,是我国自己培养的青年基因工程中、下游技术专家,是北京市有突出贡献的专家并享受国务院特殊津贴,先后主持完成了四项国家级高技术重点研究项目。兼任中国生物工程学会产业化专业委员会常务委员.北京市医药行业协会副会长、北京中关村生物工程和新医药企业协会副理事长、生化工程国家重点实验室学术委员会委员、中国药学会生物制品专业委员会委员,是“新世纪百千万人才工程”国家级人选和“首都劳动奖章”获得者。
Xu Mingbo, general manager and chairman of Shuanglu Pharmaceutical Co., Ltd., is the main sponsor, founder and core technology leader of the company. Former military Academy of Science task force leader, assistant researcher, Beijing double heron Pharmaceutical Co., Ltd. senior engineer, professor-level senior engineer, general manager, is our own training of young genetic engineering, downstream technical experts, Beijing has made outstanding contributions Experts and enjoy the special allowance of the State Council, has presided over the completion of four state-level high-tech key research projects. He is also a standing member of the Industrialization Committee of China Bioengineering Society, vice president of Beijing Pharmaceutical Industry Association, vice chairman of Beijing Zhongguancun Bioengineering and New Pharmaceutical Enterprises Association, member of Academic Committee of State Key Laboratory of Biochemical Engineering, Committee members, is “New Century Talents Project ” national candidates and “Capital Labor Medal ” winner.